Navigation Links
Anti-HIV gel being evaluated in pregnant and breastfeeding women
Date:6/20/2011

ctive drug in the mother's bloodstream, and in the amniotic fluid and umbilical cord blood. The drug levels measured in umbilical cord blood were 40 times lower than drug levels in studies of HIV-infected women who took the tablet form of tenofovir while they were pregnant. Building on these results, MTN-008 will test daily use of tenofovir gel by pregnant women for one week during third trimester pregnancy, and daily use of the gel for one week by breastfeeding mothers four to 26 weeks after they have given birth.

"By taking a cautious, step-wise approach to this research, we are ensuring the safety of both mothers and their infants," said Dr. Beigi. "Our overall goal is to find a product that women can safely use to protect against HIV during all stages of pregnancy and motherhood."

Researchers will enroll approximately 105 HIV-negative mother-infant pairs. For the pregnancy group, researchers will initially enroll 45 women between 37 and 39 weeks gestation and randomize them to receive tenofovir gel or a placebo gel. The women will apply one dose of their assigned study product (tenofovir gel or placebo gel) for seven consecutive days and undergo evaluation for side effects. Provided there are no safety concerns, researchers will then enroll a second group of 45 pregnant women who will follow the same seven-day regimen. The second group of women will enter the study earlier in their third trimester -- between 34 and 36 weeks gestation. For the group of breastfeeding women, all 15 participants who are enrolled will use tenofovir gel daily for seven days.

The researchers plan to evaluate the safety of the drug and assess how much active drug is absorbed during pregnancy and subsequently transferred to the fetus. In breastfeeding mothers, the researchers will also measure drug levels in breast milk and assess whether the drug is transferred to the baby. Depending on results of the study, which are expected in late 2012, the re
'/>"/>

Contact: Clare Collins
collcx@upmc.edu
412-641-7299
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Anti-HIV gel leadership team acknowledged for outstanding achievement in world health
2. Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
3. New Anti-HIV Weapons Found in Immune System
4. Anti-HIV Drugs May Help Prevent Spread of Virus
5. Being Born-Again Linked to More Brain Atrophy: Study
6. What do policymakers know about the factors influencing peoples well-being?
7. Biting back: Research could lead to mosquitoes being susceptible to diseases they transmit
8. Teen Boys With Autism at Risk of Being Bullied: Study
9. Being Housebound Linked to Alzheimers in Elderly
10. Effective pain management crucial to older adults well-being
11. Measles not being reported
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... The Holiday Inn Westbury - Long Island ... Association to donate various items consisting of practical, ... such items.The Association's program is aimed toward helping over ... nursing homes, assisted living facilities and nursing homes. The ... of seniors throughout the Long Island area. The Holiday ...
(Date:11/24/2014)... 2014 Mental health issues affect ... break up families, ruin careers, and generally destroy ... those that suffer,” says Hardy Nutritionals® ... that our specialized nutritional treatments can reverse these ... “Mind Over Matter”, the premiere episode of O2 ...
(Date:11/24/2014)... SafeHandles™ announced that they will be featured ... Jr, airing via Discovery Channel. Dates and show times ... non-invasive, replaceable, and affordable germ protective device. This segment ... and adhesives to promote hand hygiene in high traffic ... SafeHandles is the desire to make a positive impact ...
(Date:11/24/2014)... New York (PRWEB) November 24, 2014 Gersowitz ... today that it has received national Tier recognition in the ... Firms.” Achieving a tiered ranking signals a unique combination of ... are very proud to receive this honor and especially grateful ... made this important honor and ranking possible,” said Jeff S. ...
(Date:11/24/2014)... PA (PRWEB) November 24, 2014 "My ... he was trying to cross the street in his ... driver never saw him. I came up with this ... visible at night." , He developed the Safety Lites ... or in low-lighting conditions. The device ensures that motorists ...
Breaking Medicine News(10 mins):Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2
... screened, treated more aggressively if deemed at risk, researchers ... have linked a genetic pattern to the likelihood that ... relapse. , The finding could lead doctors to screen ... more aggressively from the time of diagnosis, the researchers ...
... ... woman, and there is no way to prevent it. Although there is no definite way to ... natural remedies for menopause - believes that its symptoms can be cut short through the use ... Beverly ...
... ten patients who discontinued their overactive bladder (OAB) medication said ... couldn,t tolerate it, according to research in the May issue ... also discovered that smokers, men with enlarged prostates and people ... taking prescription drugs for bladder problems. The team surveyed ...
... the long-term economic consequences of childhood psychological disorders finds ... as adults, costing $2.1 trillion over the lifetimes of ... conditions such as depression and substance abuse are less ... their income reduced by about 20 percent over their ...
... ... document collaboration and video conferencing tool on the market, leveraging the secure NTT America ... ... VRMeetings, Inc. today announced the U.S. launch of MeetingPlaza, the world’s most advanced document ...
... ... pharmaceutical value-added programs and account managers among key managed care influencers. , ... Health Industries ... research project that provides strategic and tactical information to assist pharmaceutical manufacturers in ...
Cached Medicine News:Health News:Genetic Pattern May Predict Leukemia Relapse 2Health News:Can Menopause Be Shortened? Dr. Ershadi Discusses Possibility 2Health News:Can Menopause Be Shortened? Dr. Ershadi Discusses Possibility 3Health News:Unmet expectations and smoking prove key factors in quitting bladder medication 2Health News:Unmet expectations and smoking prove key factors in quitting bladder medication 3Health News:Childhood psychological problems create long-term economic losses, study finds 2Health News:Childhood psychological problems create long-term economic losses, study finds 3Health News:VRMeetings, Inc. Deploys the most Advanced Web-Based Video Conferencing and Document Collaboration Service over the Managed NTT America IT Infrastructure 2Health News:VRMeetings, Inc. Deploys the most Advanced Web-Based Video Conferencing and Document Collaboration Service over the Managed NTT America IT Infrastructure 3Health News:VRMeetings, Inc. Deploys the most Advanced Web-Based Video Conferencing and Document Collaboration Service over the Managed NTT America IT Infrastructure 4Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 2Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 3
(Date:11/22/2014)... , Nov. 21, 2014  CytoSorbents Corporation ... its European Union approved CytoSorb® cytokine adsorber to ... awarded the Beacon of Light Award at last ... Dr. Phillip Chan , ... an honor to be recognized by the New ...
(Date:11/22/2014)... -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on ... quarter sales ended September 30, 2014 of $8.7 million ... months ended September 2014 and a $38,000 loss for the ... quarter is usually a seasonable weak period due to the ... many countries worldwide, we are proud to announce record sales ...
(Date:11/21/2014)... Mass. , Nov. 21, 2014  Alere Inc. ... rapid diagnostic tests, has appointed Juliet Cunningham ... role, Cunningham will be responsible for driving communications with ... execute on a series of changes to increase shareholder ... progress to investors," said Namal Nawana, Chief Executive Officer. ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced today ... will be released on Friday, February 25, 2011, at ... Johnson, Chief Executive Officer, and David Gionco, Group Vice ... community conference call and webcast at 9:00 a.m. Eastern ...
... SCOTTSDALE, Ariz., Feb. 17, 2011 ... interoperable workflow solutions, announced today that the University ... Physician Insight Plus™, one of many performance ... with Cleveland Clinic. The performance improvement dashboards are designed ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2010 Results Conference Call on Friday, February 25, 2011 2University of North Carolina Hospitals Selects Carefx Business Intelligence Dashboards To Drive Performance Improvement 2University of North Carolina Hospitals Selects Carefx Business Intelligence Dashboards To Drive Performance Improvement 3
... for the Quantitative Measurement ... S level based on ... Inhibition by STA© Analyzers. ... of Protein S; Human ...
Immuno-turbidimetric Assay for Antithrombin III Antigen. Suspension of microlatex particles coated with specific antibodies....
Enzyme Immunoassay of Protein C Antigenby ELISA Method, 96 tests...
Colorimetric Assay of Unfractionated and Low Molecular Weight Heparins by STA© Analyzers. Lyophilized, patent-pending chromogenic substate, CBS 52.44 of ~8.8 moles/vial and bovine factorXa ~2.2 ...
Medicine Products: